Recombinetics Announces Collaboration with Mayo Clinic to Grow Human Cardiomyocytes in Swine for Exo-transplantation
Recombinetics today announced a multi-project, collaborative research and development agreement with Mayo Clinic to advance capabilities to bioengineer human stem cells within swine models. The collaboration is focused on utilizing human stem cells to produce human tissue products in a surrogate pig for exo-transplantation back into humans. These regenerative stem [...]
Our company's work in exo-transplantation for regenerative medicine is featured on Facebook Watch's On the Fringe show. Click on the box below to watch it.